MedTrace Logo

2D Speckle-tracking Echocardiography in Chemotherapy-induced Cardiomyopathy With Cardiovascular Risk Factors

NCT04547465 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-08-08

No results posted yet for this study

Summary

The aims of this study is to evaluate the role of 2D speckle-tracking echocardiography in diagnosis chemotherapy related left ventricular dysfunction in breast cancer patients with cardiovascular risks

Conditions

  • Cardiomyopathy Due to Drug
  • Breast Cancer
  • Cardiovascular Risk Factor

Interventions

DIAGNOSTIC_TEST

Echocardiography

2D Speckle-tracking echocardiography

Sponsors & Collaborators

  • Gia Dinh People Hospital

    lead OTHER

Principal Investigators

  • Hai H. Nguyen, Ph.D · Cardiology Department

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2023-10-30
Completion
2023-12-30

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04547465 on ClinicalTrials.gov